论文部分内容阅读
目的观察中药肺癌方辅治痰瘀阻肺型晚期肺癌的效果。方法选择收治的痰瘀阻肺型晚期肺癌患者110例,将其随机分为研究组与对照组各55例。对照组单纯应用常规对症治疗,研究组在此基础上应用中药肺癌方治疗。治疗4周后,观察比较2组患者近期临床疗效及治疗期间的不良反应。结果 2组患者治疗近期治疗的总有效率为21.82%高于对照组的7.27%(P<0.05);疾病控制率为89.09%高于对照组的72.73%(P<0.05)。研究组治疗期间不良反应发生率21.82%低于对照组的40.00%(P<0.05)。结论中药肺癌方治疗痰瘀阻肺型晚期肺癌疗效确切,可以有效减缓疾病进展,安全性佳,适于临床应用与推广。
Objective To observe the effect of traditional Chinese medicine on lung cancer in treating lung cancer with phlegm-stasis syndrome. Methods One hundred and ten patients with advanced lung cancer of phlegm - stasis type selected for treatment were selected and randomly divided into study group and control group with 55 cases each. Control group simply used conventional symptomatic treatment, the study group on the basis of traditional Chinese medicine lung cancer treatment. After 4 weeks of treatment, the short-term clinical efficacy and adverse reaction during treatment were observed and compared between the two groups. Results The total effective rate of the two groups was 21.82%, which was higher than that of the control group (7.27%, P <0.05). The disease control rate was 89.09%, which was higher than that of the control group (72.73%, P <0.05). The incidence of adverse reactions in the study group during the treatment was 21.82% lower than that in the control group (40.00%, P <0.05). Conclusion The treatment of lung cancer with traditional Chinese medicine lung cancer is effective in treating advanced lung cancer with phlegm-stasis lung disease, which can effectively slow the progress of the disease and is safe and suitable for clinical application and promotion.